{{Drugbox
| Verifiedfields = changed
| image = Acetiromate skeletal.svg
| IUPAC_name = 4-(4-acetyloxy-3-iodophenoxy)-3,5-diiodobenzoic acid

<!--Identifiers-->
| CAS_number = 2260-08-4
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8Q5153W1NW
| PubChem =  16748
| ChemSpiderID = 15877
| ChEMBL = 2105921
| ATC_prefix = none
 
<!--Chemical data-->
| C=15 | H=9 | I=3 | O=5 
| molecular_weight = 649.941 g/mol<ref>{{cite web|url=http://www.chemicalbook.com/ProductChemicalPropertiesCB01117248_EN.htm|title=Acetiromate Basic information}}</ref>
| smiles = CC(=O)OC1=C(C=C(C=C1)OC2=C(C=C(C=C2I)C(=O)O)I)I
| StdInChI=1S/C15H9I3O5/c1-7(19)22-13-3-2-9(6-10(13)16)23-14-11(17)4-8(15(20)21)5-12(14)18/h2-6H,1H3,(H,20,21)
| StdInChIKey = AXVCIZJRCOHMQX-UHFFFAOYSA-N
}}

'''Acetiromate''' is an [[Hypolipidemic agent|antilipidemic]] [[drug]] which is used to treat [[hyperlipidemia]]. It is also known as Adecol, TBF 43, or acetyltriiodothyronine formic acid.<ref>{{cite web|url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=16748#itabs-2d|title=acetiromate - Compound Summary}}</ref>

==References==
{{reflist}}

==External links==
*{{cite journal|author=Soichi Kumaoka|year=1974|title=Long-term Administration of 3,5-Diodo-4(3'-iodo4'-acetoxyphenoxy) Benzoic Acid (Acetiromate) in Hyperlipidemic Patients|url=https://www.jstage.jst.go.jp/article/endocrj1954/21/4/21_4_355/_pdf|journal=Endocrinologia japonica|volume=21|issue=4|pages=355â€“360}}

[[Category:Hypolipidemic agents]]
[[Category:Lipid disorders]]


{{cardiovascular-drug-stub}}